• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases.

作者信息

Price Nancy

出版信息

Clin Lung Cancer. 2004 Mar;5(5):267-9. doi: 10.1016/S1525-7304(11)70347-3.

DOI:10.1016/S1525-7304(11)70347-3
PMID:15086964
Abstract
摘要

相似文献

1
Bisphosphonates to prevent skeletal morbidity in patients with lung cancer with bone metastases.双膦酸盐类药物预防肺癌骨转移患者的骨骼并发症。
Clin Lung Cancer. 2004 Mar;5(5):267-9. doi: 10.1016/S1525-7304(11)70347-3.
2
Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.骨转换标志物作为前列腺癌、肺癌及其他实体瘤骨骼并发症的预测指标
J Natl Cancer Inst. 2005 Jan 5;97(1):59-69. doi: 10.1093/jnci/dji002.
3
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses.双膦酸盐在晚期癌症管理中的作用，重点关注非小细胞肺癌。第2部分：临床研究与经济分析。
Oncology. 2005;68(1):18-22. doi: 10.1159/000084518. Epub 2005 Mar 15.
4
Skeletal morbidity in lung cancer patients with bone metastases: demonstrating the need for early diagnosis and treatment with bisphosphonates.肺癌伴骨转移患者的骨骼并发症：强调需要早期诊断和使用双膦酸盐治疗。
Lung Cancer. 2010 Jan;67(1):4-11. doi: 10.1016/j.lungcan.2009.08.020.
5
Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors: a randomized, Phase III, double-blind, placebo-controlled trial.唑来膦酸治疗非小细胞肺癌及其他实体瘤患者骨转移的长期疗效和安全性：一项随机、III期、双盲、安慰剂对照试验
Cancer. 2004 Jun 15;100(12):2613-21. doi: 10.1002/cncr.20308.
6
Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience.唑来膦酸快速输注在肺癌骨转移患者中的安全性和有效性：单机构经验
Anticancer Res. 2008 Jan-Feb;28(1B):529-33.
7
The potential application of zoledronic acid as anticancer therapy in patients with non-small-cell lung cancer.唑来膦酸在非小细胞肺癌患者中作为抗癌疗法的潜在应用。
Clin Lung Cancer. 2011 Jan;12(1):26-32. doi: 10.3816/CLC.2011.n.003.
8
Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial--the Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group.唑来膦酸与安慰剂治疗肺癌及其他实体瘤骨转移的疗效比较：一项III期双盲随机试验——唑来膦酸肺癌及其他实体瘤研究组
J Clin Oncol. 2003 Aug 15;21(16):3150-7. doi: 10.1200/JCO.2003.04.105.
9
Skeletal disease contributes substantially to morbidity and mortality in patients with lung cancer.肺癌患者的骨骼疾病严重影响其发病率和死亡率。
Clin Lung Cancer. 2009 Jul;10(4):223-9. doi: 10.3816/CLC.2009.n.030.
10
Cost-effectiveness of zoledronic acid in the management of skeletal metastases in patients with lung cancer in France, Germany, Portugal, the Netherlands, and the United kingdom.唑来膦酸在法国、德国、葡萄牙、荷兰和英国肺癌骨骼转移患者管理中的成本效益。
Clin Ther. 2011 Mar;33(3):291-304.e8. doi: 10.1016/j.clinthera.2011.04.002.

引用本文的文献

1
Advancements in Liposomal Nanomedicines: Innovative Formulations, Therapeutic Applications, and Future Directions in Precision Medicine.脂质体纳米药物的进展：创新制剂、治疗应用及精准医学的未来方向
Int J Nanomedicine. 2025 Jan 31;20:1213-1262. doi: 10.2147/IJN.S488961. eCollection 2025.
2
Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with -mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.股骨骨转移是表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）治疗的伴有突变的非小细胞肺癌患者的不良预后因素：一项回顾性多中心队列研究。
Ther Adv Med Oncol. 2024 Dec 20;16:17588359241303090. doi: 10.1177/17588359241303090. eCollection 2024.
3
Management of bone metastasis with zoledronic acid: A systematic review and Bayesian network meta-analysis.
唑来膦酸治疗骨转移：系统评价与贝叶斯网络Meta分析
J Bone Oncol. 2023 Feb 9;39:100470. doi: 10.1016/j.jbo.2023.100470. eCollection 2023 Apr.
4
Retrospective study of EGFR-mutant lung adenocarcinoma with bone metastatic clinical features.回顾性研究 EGFR 突变型肺腺癌伴骨转移的临床特征。
Cancer Rep (Hoboken). 2023 Jan;6(1):e1628. doi: 10.1002/cnr2.1628. Epub 2022 May 25.
5
Clinical analysis of patients with skeletal metastasis of lung cancer.肺癌骨骼转移患者的临床分析。
BMC Cancer. 2019 Apr 3;19(1):303. doi: 10.1186/s12885-019-5534-3.
6
What Factors Are Associated With Early Mortality in Patients Undergoing Femur Surgery for Metastatic Lung Cancer?哪些因素与接受股骨手术治疗转移性肺癌患者的早期死亡率相关？
Clin Orthop Relat Res. 2018 Sep;476(9):1815-1822. doi: 10.1007/s11999.0000000000000101.
7
Effect of synchronous solitary bone metastasectomy and lung cancer resection on non-small cell lung cancer patients.同步孤立性骨转移瘤切除术与肺癌切除术对非小细胞肺癌患者的影响。
Oncol Lett. 2016 Mar;11(3):2266-2270. doi: 10.3892/ol.2016.4190. Epub 2016 Feb 8.
8
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases.非小细胞肺癌骨转移的自然病史
Sci Rep. 2015 Dec 22;5:18670. doi: 10.1038/srep18670.
9
Bisphosphonates in the Treatment of Patients With Metastatic Breast, Lung, and Prostate Cancer: A Meta-Analysis.双膦酸盐类药物治疗转移性乳腺癌、肺癌和前列腺癌患者的Meta分析
Medicine (Baltimore). 2015 Nov;94(46):e2014. doi: 10.1097/MD.0000000000002014.
10
Metastatic Spinal Cord Compression from Non-Small-Cell Lung Cancer Treated with Surgery and Adjuvant Therapies: A Retrospective Analysis of Outcomes and Prognostic Factors in 116 Patients.手术及辅助治疗非小细胞肺癌所致转移性脊髓压迫症：116例患者的结局及预后因素回顾性分析
J Bone Joint Surg Am. 2015 Sep 2;97(17):1418-25. doi: 10.2106/JBJS.N.01124.